Table 1 Patients demography
Nadroparin (n = 278) no. (%) | Fondaparinux Sodium (n = 314) no. (%) | P-value | |
|---|---|---|---|
DVT | 23(8.3) | 47(15.0) | 0.012 |
Gender | 0.067 | ||
Female-no.(%) | 175(62.9) | 220(70.1) | |
Male-no.(%) | 103(37.1) | 94(29.9) | |
Age (mean ± SD) | 68.85 ± 10.007 | 67.06 ± 10.688 | 0.036 |
Age stratification | |||
≥ 80 year.-no. (%) | 35(12.6) | 25(8.0) | 0.573 |
65–79 year.-no. (%) | 160(57.6) | 187(59.6) | 0.325 |
<65 year.-no. (%) | 83(29.8) | 102(32.4) | 0.155 |
Comorbidity | |||
Hypertension - no. (%) | 131(47.1) | 141(44.9) | 0.589 |
Type 2 diabetes - no. (%) | 45(16.2) | 45(14.3) | 0.530 |
Coronary heart disease - no. (%) | 9(3.2) | 2(0.6) | 0.019 |
Type of surgery | 0.051 | ||
THA- no. (%) | 108(38.8) | 98(31.2) | |
TKA- no. (%) | 170(61.2) | 216(68.8) | |
Type of anesthesia | 0.243 | ||
General anesthesia- no. (%) | 96(34.5) | 123(39.2) | |
Combined spinal-epidural anesthesia- no. (%) | 182(65.5) | 191(60.8) |